Dan Brennan
Stock Analyst at TD Cowen
(3.93)
# 555
Out of 5,180 analysts
126
Total ratings
48.04%
Success rate
11.17%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Buy | $170 → $157 | $112.01 | +40.17% | 14 | Feb 26, 2026 | |
| XGN Exagen | Maintains: Buy | $13 → $10 | $2.65 | +277.36% | 1 | Feb 24, 2026 | |
| GH Guardant Health | Maintains: Buy | $130 → $135 | $86.20 | +56.61% | 4 | Feb 20, 2026 | |
| BRKR Bruker | Maintains: Hold | $53 → $43 | $34.31 | +25.33% | 4 | Feb 13, 2026 | |
| TXG 10x Genomics | Maintains: Hold | $18 → $19 | $19.81 | -4.09% | 6 | Feb 13, 2026 | |
| RVTY Revvity | Maintains: Buy | $120 → $124 | $84.78 | +46.26% | 4 | Feb 3, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $696 → $683 | $480.05 | +42.28% | 15 | Jan 30, 2026 | |
| ILMN Illumina | Maintains: Hold | $115 → $140 | $120.81 | +15.88% | 14 | Jan 7, 2026 | |
| DHR Danaher | Maintains: Buy | $260 → $270 | $183.89 | +46.83% | 7 | Jan 7, 2026 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $7.59 | +58.10% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $7 | $2.29 | +205.68% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $345 → $390 | $293.37 | +32.94% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $8 → $9 | $4.36 | +106.42% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $7.20 | +66.67% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $12.85 | +16.73% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $16.85 | +89.91% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $59.61 | +84.53% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $2.88 | -13.19% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $42.37 | +74.65% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $186.84 | -6.34% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $159.72 | +56.52% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $50.30 | +1.39% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $13.79 | +306.09% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $145.83 | +274.41% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.26 | +1,090.48% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $105.10 | +120.74% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,247.93 | -29.48% | 3 | Oct 7, 2020 |
Agilent Technologies
Feb 26, 2026
Maintains: Buy
Price Target: $170 → $157
Current: $112.01
Upside: +40.17%
Exagen
Feb 24, 2026
Maintains: Buy
Price Target: $13 → $10
Current: $2.65
Upside: +277.36%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $130 → $135
Current: $86.20
Upside: +56.61%
Bruker
Feb 13, 2026
Maintains: Hold
Price Target: $53 → $43
Current: $34.31
Upside: +25.33%
10x Genomics
Feb 13, 2026
Maintains: Hold
Price Target: $18 → $19
Current: $19.81
Upside: -4.09%
Revvity
Feb 3, 2026
Maintains: Buy
Price Target: $120 → $124
Current: $84.78
Upside: +46.26%
Thermo Fisher Scientific
Jan 30, 2026
Maintains: Buy
Price Target: $696 → $683
Current: $480.05
Upside: +42.28%
Illumina
Jan 7, 2026
Maintains: Hold
Price Target: $115 → $140
Current: $120.81
Upside: +15.88%
Danaher
Jan 7, 2026
Maintains: Buy
Price Target: $260 → $270
Current: $183.89
Upside: +46.83%
Avantor
Jan 7, 2026
Maintains: Hold
Price Target: $14 → $12
Current: $7.59
Upside: +58.10%
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $2.29
Upside: +205.68%
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $293.37
Upside: +32.94%
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $4.36
Upside: +106.42%
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $7.20
Upside: +66.67%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $12.85
Upside: +16.73%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $16.85
Upside: +89.91%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $59.61
Upside: +84.53%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $2.88
Upside: -13.19%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $42.37
Upside: +74.65%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $186.84
Upside: -6.34%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $159.72
Upside: +56.52%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $50.30
Upside: +1.39%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $13.79
Upside: +306.09%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $145.83
Upside: +274.41%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.26
Upside: +1,090.48%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $105.10
Upside: +120.74%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,247.93
Upside: -29.48%